NCT07695441

Brief Summary

This randomized crossover proof-of-concept study evaluated the effects of walking with a wearable hip exoskeleton on postprandial glycemic and physiological responses in healthy adults. Participants completed four experimental conditions: seated control, walking without the wearable hip exoskeleton, walking with the Bot-Fit device in Aqua mode, and walking with the Bot-Fit device in Boost mode. The primary aim was to determine whether walking with the wearable hip exoskeleton alters postprandial glucose responses compared with seated control and conventional walking conditions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 17, 2026

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 25, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 25, 2026

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

July 5, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 10, 2026

Completed
Last Updated

July 10, 2026

Status Verified

July 1, 2026

Enrollment Period

1 month

First QC Date

July 5, 2026

Last Update Submit

July 8, 2026

Conditions

Keywords

Wearable hip exoskeletonBot-FitPostprandial glucoseWalkingEnergy expenditureHealthy adults

Outcome Measures

Primary Outcomes (1)

  • Incremental Area Under the Curve for Postprandial Glucose

    Incremental area under the curve for postprandial glucose was calculated during the postprandial measurement period for each experimental condition.

    Up to 120 minutes after meal ingestion during each experimental trial

Secondary Outcomes (3)

  • Peak Postprandial Glucose Concentration

    Up to 120 minutes after meal ingestion during each experimental trial

  • Heart Rate Response

    From the start to the end of the 30-minute intervention or control period on each experimental trial day

  • Rating of Perceived Exertion

    Immediately after each experimental condition

Study Arms (4)

Seated Control

NO INTERVENTION

Participants remained seated during the postprandial period without walking or wearable hip exoskeleton assistance.

Walking Without Bot-Fit

ACTIVE COMPARATOR

Participants performed walking without wearing the Bot-Fit wearable hip exoskeleton.

Behavioral: Walking Without Bot-Fit

Bot-Fit Aqua Mode

EXPERIMENTAL

Participants performed walking while wearing the Bot-Fit wearable hip exoskeleton in Aqua mode.

Device: Bot-Fit Aqua Mode

Bot-Fit Boost Mode

EXPERIMENTAL

Participants performed walking while wearing the Bot-Fit wearable hip exoskeleton in Boost mode.

Device: Bot-Fit Boost Mode

Interventions

Participants performed walking without wearing the Bot-Fit wearable hip exoskeleton during the postprandial period.

Walking Without Bot-Fit

Participants performed walking while wearing the Bot-Fit wearable hip exoskeleton in Aqua mode during the postprandial period.

Bot-Fit Aqua Mode

Participants performed walking while wearing the Bot-Fit wearable hip exoskeleton in Boost mode during the postprandial period.

Bot-Fit Boost Mode

Eligibility Criteria

Age20 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy adults aged 20 to 65 years.
  • Participants who were able to complete walking trials with and without the wearable hip exoskeleton.
  • Participants who provided written informed consent before participation.

You may not qualify if:

  • Participants with diagnosed metabolic, cardiovascular, neurological, or musculoskeletal disorders.
  • Participants with conditions that could affect walking ability or safe use of the wearable hip exoskeleton.
  • Participants taking medications known to affect glucose metabolism.
  • Participants who were unable to comply with the study procedures.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHA University

Seongnam-si, Gyeonggi-do, 13503, South Korea

Location

MeSH Terms

Interventions

Walking

Intervention Hierarchy (Ancestors)

LocomotionMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaExerciseMotor Activity

Study Officials

  • Seung-Bo Park, Ph.D

    CHA University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: Each participant completed four experimental conditions in a randomized crossover design: seated control, walking without the wearable hip exoskeleton, walking with the Bot-Fit device in Aqua mode, and walking with the Bot-Fit device in Boost mode.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 5, 2026

First Posted

July 10, 2026

Study Start

March 17, 2026

Primary Completion

April 25, 2026

Study Completion

April 25, 2026

Last Updated

July 10, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will share

Deidentified individual participant data underlying the main results of the study may be shared upon reasonable request. The shared data may include postprandial glucose responses, heart rate, rating of perceived exertion, and relevant demographic and physiological variables after deidentification.

Time Frame
Data may be made available after publication of the main study results and will be available for a reasonable period thereafter.
Access Criteria
Data may be shared with qualified researchers who submit a reasonable research proposal to the corresponding author. Access will be granted only after review and approval by the investigators and, where required, appropriate institutional or ethics committee approval. Data will be shared only for scientific purposes and in a deidentified form.

Locations